(S)-1-Boc-3-hydroxypiperidine CAS 143900-44-1

1.1 Key Chiral Intermediates for Central Nervous System Drugs

Central nervous system drugs impose extremely stringent requirements on chiral purity and spatial configuration matching. A single chiral configuration serves as the core prerequisite for ensuring pharmacological efficacy and reducing toxic and side effects. With a fixed S-type chiral center, (S)-1-Boc-3-hydroxypiperidine acts directly as a parent nucleus scaffold for the molecular construction of candidate drugs targeting depression, anxiety, schizophrenia and neurodegenerative diseases.

The 3-position hydroxyl group of this compound can undergo directional transformations including oxidation, halogenation, sulfonylation, alkylation and amination to rapidly derive functional fragments such as ethers, amines and heterocyclic substituted derivatives. The Boc protecting group can be quantitatively removed under mild acidic conditions to release free secondary amines for subsequent acylation, condensation and cyclization reactions, enabling the linkage of different pharmacophores.

In the research and development of regulators targeting serotonin receptors, dopamine receptors and acetylcholine receptors, this chiral building block as the starting material enables precise control over the spatial conformation of drug molecules, enhances target binding specificity, and avoids efficacy attenuation and systemic toxicity caused by racemates. Compared with racemic 3-hydroxypiperidine derivatives, the single S-configured raw material eliminates chiral resolution steps, shortens synthetic routes, cuts industrial production costs, and meets the demand for green synthesis of active pharmaceutical ingredients (APIs).

1.3 R&D Applications in Anti-Infective and Metabolic Drugs

The application scope of this compound continues to expand in the synthesis of antibacterial, antiviral and chronic metabolic drugs. In the development of broad-spectrum antibacterial small-molecule drugs, its chiral piperidine structure improves the bacterial cell membrane penetration capacity and enhances bacteriostatic activity. For antiviral drug research, it acts as a critical side-chain intermediate for nucleoside drugs and protease inhibitors, optimizing metabolic stability and prolonging in-vivo half-life through structural modification.

In addition, for the synthesis of metabolic drugs for hypoglycemia and lipid-lowering, the S-configured chiral center regulates in-vivo metabolic pathways, alleviates hepatic metabolic burden, and lowers the risk of drug-drug interactions. The high stability of the Boc protecting group enables it to withstand strongly polar reaction systems and adapt to process conditions for the large-scale production of pharmaceutical intermediates, making it a universal chiral reagent for the simultaneous development of generic drugs and innovative medicines.

3.1 Manufacturing of Chiral Fine Chemicals and Special Intermediates

Demand for high optically pure chiral heterocyclic derivatives in the fine chemical industry is growing year by year. (S)-1-Boc-3-hydroxypiperidine is a core raw material for synthesizing chiral auxiliaries, chiral resolving agents and special fine chemicals. A series of chiral piperidine derivatives can be prepared through hydroxyl esterification, etherification and silylation modification, which are applied in the synthesis of high-end flavors and fragrances, chiral additives and agricultural chiral fungicides.

In the agrochemical sector, chiral pesticides are gradually replacing racemic counterparts due to their advantages of high activity, low residue and low toxicity. Chiral nitrogen-containing heterocyclic compounds derived from this intermediate can be used as active ingredients of plant growth regulators and selective fungicides. They bind to pathogenic target sites through precise spatial configuration, improving pesticide utilization and reducing agricultural non-point source pollution.

3.2 Modification of Functional Polymers and Medical Materials

In the fields of medical macromolecules and smart functional materials, (S)-1-Boc-3-hydroxypiperidine acts as a functional modified monomer for the synthesis of special polymers. The hydroxyl group in the molecule participates in polycondensation reactions and is incorporated into polyester, polyamide and polyurethane macromolecular segments, introducing chiral heterocyclic structures to endow materials with unique chiral recognition, biocompatibility and degradability.

Modified polymer materials can be used to prepare medical sustained-release carriers, tissue engineering scaffolds and degradable medical supplies. The chiral structure optimizes the affinity between materials and biological tissues and regulates drug loading and sustained-release rates. Meanwhile, its derivatives are applicable to the modification of chiral separation membrane materials. Chiral recognition enables efficient separation of racemic compounds, supporting industrial scenarios such as purification of pharmaceutical intermediates and separation of biological samples.

5.2 Industry Development Prospects

Driven by the accelerated global R&D of innovative drugs, upgraded policies and specifications for chiral medicines, and the rapid development of fine chemicals and green catalysis industries, the market for chiral piperidine intermediates continues to expand. As an essential chiral synthon, (S)-1-Boc-3-hydroxypiperidine witnesses surging demand in the fields of neurological drugs, antitumor small molecules, high-end generic drugs and chiral catalytic materials.

Continuous optimization of synthetic processes and the gradual implementation of low-cost green production routes will further promote the global popularization of this product in the pharmaceutical and chemical supply chain. It has become a core product in pharmaceutical foreign trade, customized synthesis and high-end reagent trading, boasting long-term application value and broad market potential.